The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126138651 12613865 1 I 20160519 20160726 20160802 20160802 EXP GB-MHRA-TPP13257440C2025561YC1468573524908 GB-009507513-1607GBR011113 MERCK 36.00 YR F Y 83.00000 KG 20160802 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126138651 12613865 1 PS MONTELUKAST SODIUM. MONTELUKAST SODIUM 1 Oral UNK U U 20829 TABLET
126138651 12613865 2 C AMOXICILLIN. AMOXICILLIN 1 1 DF, TID 159 DF 0 1 DF TID
126138651 12613865 3 C CETIRIZINE HYDROCHLORIDE. CETIRIZINE HYDROCHLORIDE 1 1 DF, QD 0 1 DF QD
126138651 12613865 4 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 1 DF, HS( AT NIGHT) 0 1 DF QD
126138651 12613865 5 C CLARITHROMYCIN. CLARITHROMYCIN 1 1 DF, BID 0 1 DF BID
126138651 12613865 6 C DOXYCYCLINE. DOXYCYCLINE 1 TWO NOW THEN ONE DAILY 0
126138651 12613865 7 C FLUTICASONE FLUTICASONEFLUTICASONE PROPIONATE 1 2 DF, BID 188 DF 0 2 DF BID
126138651 12613865 8 C HYDROXOCOBALAMIN HYDROXOCOBALAMIN 1 USE AS DIRECTED 0
126138651 12613865 9 C LANSOPRAZOLE. LANSOPRAZOLE 1 1 DF, QD 0 1 DF QD
126138651 12613865 10 C PIZOTYLINE PIZOTYLINE 1 UP TO THREE TO BE TAKEN AT NIGHT 0 QD
126138651 12613865 11 C PREDNISOLONE. PREDNISOLONE 1 Oral USE AS DIRECTED 0 TABLET
126138651 12613865 12 C ALBUTEROL. ALBUTEROL 1 WHEN REQUIRED 0 2 DF TID
126138651 12613865 13 C SERETIDE FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) 2 DF, BID 64 DF 0 2 DF BID
126138651 12613865 14 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) ONE OR TWO PUFFS TWICE A DAY TO CONTROL... 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126138651 12613865 2 Migraine prophylaxis
126138651 12613865 5 Infection
126138651 12613865 9 Ulcer
126138651 12613865 10 Migraine prophylaxis

Outcome of event

Event ID CASEID OUTC COD
126138651 12613865 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
126138651 12613865 Condition aggravated
126138651 12613865 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126138651 12613865 1 20160420 0
126138651 12613865 2 20160711 0
126138651 12613865 3 20160711 0
126138651 12613865 4 20160318 0
126138651 12613865 5 20160607 20160614 0
126138651 12613865 6 20160513 20160520 0
126138651 12613865 7 20160318 20160503 0
126138651 12613865 8 20160704 0
126138651 12613865 9 20160711 0
126138651 12613865 10 20160519 20160616 0
126138651 12613865 11 20160616 20160623 0
126138651 12613865 12 20160318 0
126138651 12613865 13 20160503 20160713 0
126138651 12613865 14 20160711 0